Los puntos clave no están disponibles para este artículo en este momento.
Significance Previous works demonstrated the role of hypoxia in tumor development and metastasis. However, the understanding how oxygen (O 2 ) gradients regulate early stages of tumor metastasis is lacking. Leveraging our O 2 -controlling hydrogel, we generated a 3D in vitro model that enables us to analyze cancer cell responses to O 2 gradients and small-molecule inhibitors. Using this approach, we present a previously unidentified concept in which O 2 acts as a 3D physicotactic agent during sarcoma tumor invasion, findings that are important for the understanding of the metastatic process. Through this concept, we also establish the 3D in vitro model as a platform for testing therapeutic targets and interventions for the treatment of sarcoma and potentially other cancers.
Lewis et al. (Tue,) studied this question.